Clinical Trial Update: Lung Microbiome and Inflammation in Early COPD

View source ↗

Summary

A clinical trial investigating the lung microbiome and inflammation in early COPD is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: NYU Langone Health | Conditions: Chronic Obstuctive Pulmonary Disease | Status: RECRUITING